CarDiac magnEtic Resonance for prophylactic Implantable-cardioVerter defibrillAtor ThErapy in Non-Ischaemic dilated CardioMyopathy: an international RegistryAndrea Igoren Guaricci, Nazario Carrabba, Pier Giorgio Masci et al.|EP Europace|2020Cited by 65
Cardiac Magnetic Resonance for Prophylactic Implantable-Cardioverter Defibrillator Therapy in Ischemic CardiomyopathyGianluca Pontone, Nicola Sverzellati, Andrea Igoren Guaricci et al.|JACC. Cardiovascular imaging|2023Cited by 41
Prognostic impact of late gadolinium enhancement in the risk stratification of heart transplant patientsPatrizia Pedrotti, Ornella Rimoldi, Claudia Vittori et al.|European Heart Journal - Cardiovascular Imaging|2016Cited by 34
CarDiac magnEtic Resonance for prophylactic Implantable cardioVerter defibrillAtor ThErapy in Non-Dilated Left Ventricular Cardiomyopathy: a sub-study from the DERIVATE registryIsabella Leo, U. Joseph Schoepf, Santo Dellegrottaglie et al.|European Heart Journal - Cardiovascular Imaging|2025Cited by 18
Cardiac magnetic resonance for prophylactic implantable-cardioverter defibrillator therapy international study: prognostic value of cardiac magnetic resonance-derived right ventricular parameters substudySubhi J. Al’Aref, Cristina Presicci, Ahmed Altibi et al.|European Heart Journal - Cardiovascular Imaging|2022Cited by 17